AQR Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150K | Sell |
96,234
-48,566
| -34% | -$70.6K | ﹤0.01% | 3645 |
|
|
2025
Q4 | $167K | Sell |
144,800
-158,131
| -52% | -$217K | ﹤0.01% | 3396 |
|
|
2025
Q3 | $409K | Sell |
302,931
-1,099,279
| -78% | -$1.25M | ﹤0.01% | 2913 |
|
|
2025
Q2 | $1.33M | Buy |
1,402,210
+228,985
| +20% | +$148K | ﹤0.01% | 2030 |
|
|
2025
Q1 | $541K | Buy |
+1,173,225
| New | +$740K | ﹤0.01% | 2388 |
|
|
2023
Q4 | – | Sell |
-29,558
| Closed | -$32.2K | – | 2396 |
|
|
2023
Q3 | $32.2K | Buy |
29,558
+1,501
| +5% | +$2.63K | ﹤0.01% | 2299 |
|
|
2023
Q2 | $64.3K | Buy |
+28,057
| New | +$74.5K | ﹤0.01% | 2160 |
|
|
2023
Q1 | – | Sell |
-47,014
| Closed | -$89.8K | – | 2220 |
|
|
2022
Q4 | $89.8K | Sell |
47,014
-253,205
| -84% | -$539K | ﹤0.01% | 2148 |
|
|
2022
Q3 | $721K | Buy |
+300,219
| New | +$831K | ﹤0.01% | 1646 |
|
|
2022
Q2 | – | Sell |
-47,677
| Closed | -$100K | – | 2248 |
|
|
2022
Q1 | $100K | Sell |
47,677
-71,597
| -60% | -$198K | ﹤0.01% | 2137 |
|
|
2021
Q4 | $470K | Sell |
119,274
-84,085
| -41% | -$408K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $978K | Sell |
203,359
-121,645
| -37% | -$499K | ﹤0.01% | 1555 |
|
|
2021
Q2 | $1.49M | Buy |
325,004
+85,817
| +36% | +$413K | ﹤0.01% | 1381 |
|
|
2021
Q1 | $1.4M | Buy |
239,187
+117,784
| +97% | +$816K | ﹤0.01% | 1402 |
|
|
2020
Q4 | $415K | Sell |
121,403
-521,750
| -81% | -$995K | ﹤0.01% | 1852 |
|
|
2020
Q3 | $926K | Sell |
643,153
-561,880
| -47% | -$1M | ﹤0.01% | 1443 |
|
|
2020
Q2 | $2.4M | Sell |
1,205,033
-238,403
| -17% | -$467K | ﹤0.01% | 1076 |
|
|
2020
Q1 | $2.81M | Buy |
1,443,436
+854,990
| +145% | +$2.54M | ﹤0.01% | 965 |
|
|
2019
Q4 | $2.44M | Buy |
588,446
+544,636
| +1,243% | +$2.1M | ﹤0.01% | 1192 |
|
|
2019
Q3 | $132K | Buy |
+43,810
| New | +$136K | ﹤0.01% | 2060 |
|
|
2017
Q4 | – | Sell |
-13,248
| Closed | -$163K | – | 2252 |
|
|
2017
Q3 | $163K | Sell |
13,248
-10,218
| -44% | -$151K | ﹤0.01% | 2194 |
|
|
2017
Q2 | $386K | Sell |
23,466
-15,704
| -40% | -$243K | ﹤0.01% | 1974 |
|
|
2017
Q1 | $562K | Sell |
39,170
-55,855
| -59% | -$829K | ﹤0.01% | 1851 |
|
|
2016
Q4 | $1.31M | Sell |
95,025
-19,134
| -17% | -$307K | ﹤0.01% | 1606 |
|
|
2016
Q3 | $2.06M | Buy |
114,159
+11,082
| +11% | +$178K | ﹤0.01% | 1402 |
|
|
2016
Q2 | $1.48M | Buy |
103,077
+35,346
| +52% | +$479K | ﹤0.01% | 1453 |
|
|
2016
Q1 | $809K | Sell |
67,731
-5,008
| -7% | -$52.5K | ﹤0.01% | 1661 |
|
|
2015
Q4 | $968K | Buy |
72,739
+61,174
| +529% | +$752K | ﹤0.01% | 1588 |
|
|
2015
Q3 | $124K | Sell |
11,565
-26,303
| -69% | -$287K | ﹤0.01% | 2113 |
|
|
2015
Q2 | $305K | Buy |
+37,868
| New | +$278K | ﹤0.01% | 1976 |
|
Other funds holding LXRX
AG
SL
SC
VCM
